Physician profile
Mohammad M Islam
NPI 1346325263
$802.67
in general payments reported to CMS, 2019-2025
10 companies · $16.24 in 2025
The $16.24 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $34.55 · 2021: $48.98 · 2022: $40.74 · 2023: $21.56 · 2024: $23.58 · 2025: $16.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $528.74 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.51 | 2020-2021 | |
| Pfizer INC. | $49.47 | 2019 | |
| Bioxcel Therapeutics, INC. | $45.14 | 2023-2024 | Igalmi |
| Brainsway USA INC | $40.74 | 2022 | |
| Covidien LP | $22.61 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.50 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $16.52 | 2021 | |
| Novo Nordisk INC | $16.24 | 2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $16.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Islam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.